Finally, administration of an anti-PDIA3 antibody into EF43.fgf4 tumor-bearing mice confirmed accessibility of PDIA3 through the systemic circulation (Ozawa et al., 2008; Figure 2—figure supplement 1A). This evidence concerns the gene PDIA3 and neoplasm.